Eli L. Thomssen

Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI.

Apjohn Group LLC invests in pharamaceutical companies. It works with innovators to launch life science companies. The company is headquartered in Kalamazoo, MI.

Apjohn Group LLC invests in pharamaceutical companies. It works with innovators to launch life science companies. The company is headquartered in Kalamazoo, MI.

Adlore, Inc. is a medical device company that has developed a new device called Senlore™ to treat and monitor ulcerated wounds. The company is based in Kalamazoo, MI and was founded in 2019 by Eli L. Thomssen. Adlore™ aims to improve diabetic foot ulcer healing rates, which is a significant healthcare problem worldwide, as diabetes mellitus imposes a major economic burden on patients and the healthcare industry.

Adlore, Inc. is a medical device company that has developed a new device called Senlore™ to treat and monitor ulcerated wounds. The company is based in Kalamazoo, MI and was founded in 2019 by Eli L. Thomssen. Adlore™ aims to improve diabetic foot ulcer healing rates, which is a significant healthcare problem worldwide, as diabetes mellitus imposes a major economic burden on patients and the healthcare industry.

Adlore, Inc. is a medical device company that has developed a new device called Senlore™ to treat and monitor ulcerated wounds. The company is based in Kalamazoo, MI and was founded in 2019 by Eli L. Thomssen. Adlore™ aims to improve diabetic foot ulcer healing rates, which is a significant healthcare problem worldwide, as diabetes mellitus imposes a major economic burden on patients and the healthcare industry.

Adlore, Inc. is a medical device company that has developed a new device called Senlore™ to treat and monitor ulcerated wounds. The company is based in Kalamazoo, MI and was founded in 2019 by Eli L. Thomssen. Adlore™ aims to improve diabetic foot ulcer healing rates, which is a significant healthcare problem worldwide, as diabetes mellitus imposes a major economic burden on patients and the healthcare industry.